Allergy and Infectious Diseases
  • Print
   
   

Falcone and Stolnik Labs are New Members of the Nanovac Consortium

We have recently become members of the Nanovac Consortium. The Nanovac consortium is a fast growing international network of research groups and SMEs led by the Medway School of Pharmacy, interested in developing nanoconjugates and vaccines in particular - but not exclusively - for the treatment of allergic and inflammatory diseases. We are aiming to attract Horizon 2020 funding to further develop our ideas for innovative treatments.

Nanovac Consortium

More information is available here.

 

Allergy and Infectious Diseases

The University of Nottingham
University Park
Nottingham, NG7 2RD


telephone:+44(0) 115 84 66073
email:franco.falcone@nottingham.ac.uk